Salmonella Typhi Bactericidal Antibodies Reduce Disease Severity but Do Not Protect against Typhoid Fever in a Controlled Human Infection Model-Reference-Cited by-同舟云学术

Salmonella Typhi Bactericidal Antibodies Reduce Disease Severity but Do Not Protect against Typhoid Fever in a Controlled Human Infection Model

Published:2018-01-17 Issue: Volume:8 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Juel Helene B.,Thomaides-Brears Helena B.,Darton Thomas C.,Jones Claire,Jones Elizabeth,Shrestha Sonu,Sie Rebecca,Eustace Andrew,Galal Ushma,Kurupati Prathiba,Van Tan T.,Thieu Nga T. V.,Baker Stephen,Blohmke Christoph J.,Pollard Andrew J.

Funder

Wellcome Trust

European Commission

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference47 articles.

1. The burden of typhoid fever in low- and middle-income countries: a meta-regression approach;Antillón;PLoS Negl Trop Dis,2017

2. Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment;Mogasale;Lancet Glob Health,2014

3. Salmonella chronic carriage: epidemiology, diagnosis and gallbladder persistence;Gunn;Trends Microbiol,2014

4. Typhoid vaccines: WHO position paper;Wkly Epidemiol Rec,2008

5. Vaccines for preventing typhoid fever;Anwar;Cochrane Database Syst Rev,2014

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of controlled human infection models to identify correlates of protection for invasive Salmonella vaccines;Frontiers in Immunology;2024-08-27

2. Typhoid fever;Nature Reviews Disease Primers;2023-12-14

3. Immunogenicity and protective efficacy of nanoparticle formulations of L-SseB against Salmonella infection;Frontiers in Immunology;2023-06-30

4. Salmonellacidal antibody response to Salmonella enterica serovar Typhi in enteric fever and after vaccination with Vi capsular polysaccharide;International Journal of Infectious Diseases;2022-08

5. A typhoid fever protein capsular matrix vaccine candidate formulated with Advax-CpG adjuvant induces a robust and durable anti-typhoid Vi polysaccharide antibody response in mice, rabbits and nonhuman primates;Vaccine;2022-07